Global General Anesthesia Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global General Anesthesia Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030


General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.

According to our (Global Info Research) latest study, the global General Anesthesia Drugs market size was valued at US$ 4171 million in 2023 and is forecast to a readjusted size of USD 5264 million by 2030 with a CAGR of 3.4% during review period.

Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.

This report is a detailed and comprehensive analysis for global General Anesthesia Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global General Anesthesia Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030

Global General Anesthesia Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030

Global General Anesthesia Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030

Global General Anesthesia Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for General Anesthesia Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

General Anesthesia Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others

Market segment by Application
Intravenous Anesthetics
Inhalational Anesthetics

Major players covered
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe General Anesthesia Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of General Anesthesia Drugs, with price, sales quantity, revenue, and global market share of General Anesthesia Drugs from 2019 to 2024.

Chapter 3, the General Anesthesia Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the General Anesthesia Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and General Anesthesia Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of General Anesthesia Drugs.

Chapter 14 and 15, to describe General Anesthesia Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global General Anesthesia Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Propofol
1.3.3 Sevoflurane
1.3.4 Remifentanil
1.3.5 Etomidate
1.3.6 Isoflurane
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global General Anesthesia Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Intravenous Anesthetics
1.4.3 Inhalational Anesthetics
1.5 Global General Anesthesia Drugs Market Size & Forecast
1.5.1 Global General Anesthesia Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global General Anesthesia Drugs Sales Quantity (2019-2030)
1.5.3 Global General Anesthesia Drugs Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Aspen Pharma
2.1.1 Aspen Pharma Details
2.1.2 Aspen Pharma Major Business
2.1.3 Aspen Pharma General Anesthesia Drugs Product and Services
2.1.4 Aspen Pharma General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Aspen Pharma Recent Developments/Updates
2.2 Fresenius-Kabi
2.2.1 Fresenius-Kabi Details
2.2.2 Fresenius-Kabi Major Business
2.2.3 Fresenius-Kabi General Anesthesia Drugs Product and Services
2.2.4 Fresenius-Kabi General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Fresenius-Kabi Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie General Anesthesia Drugs Product and Services
2.3.4 AbbVie General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AbbVie Recent Developments/Updates
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare General Anesthesia Drugs Product and Services
2.4.4 Baxter Healthcare General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Baxter Healthcare Recent Developments/Updates
2.5 B.Braun
2.5.1 B.Braun Details
2.5.2 B.Braun Major Business
2.5.3 B.Braun General Anesthesia Drugs Product and Services
2.5.4 B.Braun General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 B.Braun Recent Developments/Updates
2.6 Maruishi
2.6.1 Maruishi Details
2.6.2 Maruishi Major Business
2.6.3 Maruishi General Anesthesia Drugs Product and Services
2.6.4 Maruishi General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Maruishi Recent Developments/Updates
2.7 Piramal
2.7.1 Piramal Details
2.7.2 Piramal Major Business
2.7.3 Piramal General Anesthesia Drugs Product and Services
2.7.4 Piramal General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Piramal Recent Developments/Updates
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
2.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
2.9 Yichang Humanwell
2.9.1 Yichang Humanwell Details
2.9.2 Yichang Humanwell Major Business
2.9.3 Yichang Humanwell General Anesthesia Drugs Product and Services
2.9.4 Yichang Humanwell General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Yichang Humanwell Recent Developments/Updates
2.10 Nhwa
2.10.1 Nhwa Details
2.10.2 Nhwa Major Business
2.10.3 Nhwa General Anesthesia Drugs Product and Services
2.10.4 Nhwa General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nhwa Recent Developments/Updates
2.11 Hengrui
2.11.1 Hengrui Details
2.11.2 Hengrui Major Business
2.11.3 Hengrui General Anesthesia Drugs Product and Services
2.11.4 Hengrui General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hengrui Recent Developments/Updates
2.12 Xi'an Libang
2.12.1 Xi'an Libang Details
2.12.2 Xi'an Libang Major Business
2.12.3 Xi'an Libang General Anesthesia Drugs Product and Services
2.12.4 Xi'an Libang General Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Xi'an Libang Recent Developments/Updates
3 Competitive Environment: General Anesthesia Drugs by Manufacturer
3.1 Global General Anesthesia Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global General Anesthesia Drugs Revenue by Manufacturer (2019-2024)
3.3 Global General Anesthesia Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of General Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 General Anesthesia Drugs Manufacturer Market Share in 2023
3.4.3 Top 6 General Anesthesia Drugs Manufacturer Market Share in 2023
3.5 General Anesthesia Drugs Market: Overall Company Footprint Analysis
3.5.1 General Anesthesia Drugs Market: Region Footprint
3.5.2 General Anesthesia Drugs Market: Company Product Type Footprint
3.5.3 General Anesthesia Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global General Anesthesia Drugs Market Size by Region
4.1.1 Global General Anesthesia Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global General Anesthesia Drugs Consumption Value by Region (2019-2030)
4.1.3 Global General Anesthesia Drugs Average Price by Region (2019-2030)
4.2 North America General Anesthesia Drugs Consumption Value (2019-2030)
4.3 Europe General Anesthesia Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific General Anesthesia Drugs Consumption Value (2019-2030)
4.5 South America General Anesthesia Drugs Consumption Value (2019-2030)
4.6 Middle East & Africa General Anesthesia Drugs Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global General Anesthesia Drugs Sales Quantity by Type (2019-2030)
5.2 Global General Anesthesia Drugs Consumption Value by Type (2019-2030)
5.3 Global General Anesthesia Drugs Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global General Anesthesia Drugs Sales Quantity by Application (2019-2030)
6.2 Global General Anesthesia Drugs Consumption Value by Application (2019-2030)
6.3 Global General Anesthesia Drugs Average Price by Application (2019-2030)
7 North America
7.1 North America General Anesthesia Drugs Sales Quantity by Type (2019-2030)
7.2 North America General Anesthesia Drugs Sales Quantity by Application (2019-2030)
7.3 North America General Anesthesia Drugs Market Size by Country
7.3.1 North America General Anesthesia Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America General Anesthesia Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe General Anesthesia Drugs Sales Quantity by Type (2019-2030)
8.2 Europe General Anesthesia Drugs Sales Quantity by Application (2019-2030)
8.3 Europe General Anesthesia Drugs Market Size by Country
8.3.1 Europe General Anesthesia Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe General Anesthesia Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific General Anesthesia Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific General Anesthesia Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific General Anesthesia Drugs Market Size by Region
9.3.1 Asia-Pacific General Anesthesia Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific General Anesthesia Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America General Anesthesia Drugs Sales Quantity by Type (2019-2030)
10.2 South America General Anesthesia Drugs Sales Quantity by Application (2019-2030)
10.3 South America General Anesthesia Drugs Market Size by Country
10.3.1 South America General Anesthesia Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America General Anesthesia Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa General Anesthesia Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa General Anesthesia Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa General Anesthesia Drugs Market Size by Country
11.3.1 Middle East & Africa General Anesthesia Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa General Anesthesia Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 General Anesthesia Drugs Market Drivers
12.2 General Anesthesia Drugs Market Restraints
12.3 General Anesthesia Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of General Anesthesia Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of General Anesthesia Drugs
13.3 General Anesthesia Drugs Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 General Anesthesia Drugs Typical Distributors
14.3 General Anesthesia Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings